Back
Immunovant Stock Predictions
![](/images/offers/ims/large/offer7.jpg)
Wall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%
Click here to see his new prediction.
Buy
64
IMVT
Immunovant
Last Price:
34.06
Seasonality Move:
51.14%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer1.jpg)
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.Immunovant Stock Forecast
- Over the next 52 weeks, Immunovant has on average historically risen by 108.7% based on the past 5 years of stock performance.
- Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Immunovant Stock Undervalued?
The current Immunovant [IMVT] share price is $34.00. The Score for IMVT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal. - IMVT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Immunovant Stock Go Up Next Year?
- Over the next 52 weeks, Immunovant has on average historically risen by 108.7% based on the past 5 years of stock performance.
Immunovant Stock Rating
Buy
64
Immunovant (IMVT)
is a Buy
Is Immunovant overpriced?
- Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Immunovant Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com
52-Week Data
52-Week High:
45.58
52-Week Low:
19.50
Prediction Charts
Market Cap:
4.98B
Price in USD:
34.00
Volume:
1.44M
Beta:
0.72
Technical Analysis
SMA50:
29.49
SMA100:
28.75
SMA200:
32.72
52-Wk Change:
47.7%
Stock Predictions
-
Is Immunovant stock public?
Yes, Immunovant is a publicly traded company. -
What is the Immunovant stock quote today?
The Immunovant stock price is 34.00 USD today. -
How to buy Immunovant stock online?
You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-19 | 29.64 | 31.17 | 31.44 | 29.63 |
Aug-20 | 31.18 | 31.52 | 31.60 | 30.60 |
Aug-21 | 31.58 | 32.46 | 32.64 | 31.26 |
Aug-22 | 32.58 | 31.40 | 32.69 | 31.33 |
Aug-23 | 31.67 | 32.42 | 32.54 | 31.30 |
Aug-26 | 32.40 | 32.02 | 32.77 | 31.78 |
Aug-27 | 32.01 | 31.72 | 32.13 | 31.15 |
Aug-28 | 31.80 | 31.35 | 31.83 | 31.07 |
Aug-29 | 31.70 | 30.98 | 31.99 | 30.96 |
Aug-30 | 31.16 | 30.90 | 31.51 | 30.78 |
Sep-3 | 30.98 | 30.44 | 31.67 | 30.01 |
Sep-4 | 30.15 | 30.69 | 30.73 | 29.79 |
Sep-5 | 31.10 | 33.62 | 33.69 | 31.05 |
Sep-6 | 34.14 | 34.00 | 34.47 | 32.95 |
Immunovant Earnings
Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunovant Forecast Revenue Growth
Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.65 per share.
* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.